Carcinoma in situ of prostate digital illustration

Carcinoma in situ of prostate Save


ICD-10 code: D07.5

Disease category: D07.5: Carcinoma in situ of prostate

Carcinoma in situ of prostate: Understanding the Basics

Carcinoma in situ of the prostate is a type of cancer that affects the cells in the prostate gland. It is a non-invasive form of cancer, meaning that it has not spread beyond the prostate gland. This type of cancer is often detected during routine screenings, such as a prostate-specific antigen (PSA) blood test or a digital rectal exam (DRE).

While carcinoma in situ of the prostate is a type of cancer, it is important to note that not all cases of this condition will progress to invasive prostate cancer. In some cases, the cancer may remain in situ, meaning that it remains within the prostate gland and does not spread.

Symptoms

Since carcinoma in situ of the prostate is non-invasive, it may not cause any symptoms. However, some men may experience symptoms such as:

  1. Difficulty urinating
  2. Frequent urination
  3. Blood in the urine or semen
  4. Painful ejaculation

If you experience any of these symptoms, it is important to see your healthcare provider for an evaluation.

Risk Factors

There are several factors that may increase your risk of developing carcinoma in situ of the prostate, including:

  • Age: The risk of developing prostate cancer increases with age.
  • Race: African American men have a higher risk of developing prostate cancer than men of other races.
  • Family history: If you have a family history of prostate cancer, you may be at a higher risk of developing the condition.
  • Diet: A diet high in red meat and high-fat dairy products may increase your risk of developing prostate cancer.
Diagnosis

If your healthcare provider suspects that you may have carcinoma in situ of the prostate, they may order additional tests to confirm the diagnosis. These may include:

  • Prostate-specific antigen (PSA) blood test
  • Digital rectal exam (DRE)
  • Prostate biopsy

If a diagnosis of carcinoma in situ of the prostate is confirmed, your healthcare provider may recommend additional tests to determine the extent of the cancer and whether it has spread outside of the prostate gland.

In conclusion, carcinoma in situ of the prostate is a non-invasive form of cancer that affects the cells in the prostate gland. While not all cases of this condition will progress to invasive prostate cancer, it is important to be aware of the risk factors and symptoms associated with the condition and to

Treatment of Carcinoma in situ of prostate:

Treatment Options for Carcinoma in Situ of Prostate
Carcinoma in situ of the prostate is a type of cancer that is still confined to the prostate gland. It is a very early stage of prostate cancer and can be treated effectively. The treatment options for carcinoma in situ of prostate may vary depending on the individual case, but here are some of the most common options:
  1. To see full information about treatment please Sign up or Log in